Skip to main content
Journal of Korean Medical Science logoLink to Journal of Korean Medical Science
. 2009 Jul 29;24(4):636–640. doi: 10.3346/jkms.2009.24.4.636

The Area of Ground Glass Opacities of the Lungs as a Predictive Factor in Acute Paraquat Intoxication

Yung-Tong Kim 2, Sung-Shick Jou 2, Hae-Sung Lee 1, Hyo-Wook Gil 1, Jong-Oh Yang 1, Eun-Young Lee 1, Sae-Yong Hong 1,
PMCID: PMC2719202  PMID: 19654945

Abstract

Even though plasma paraquat (PQ) levels have known to be an informative predictor, many patients succumb at low PQ levels in acute PQ intoxication. This study was designed to see whether the high resolution computerized tomography (HRCT) of the lungs would be a predictive measure in acute PQ intoxication. HRCT of the lungs was obtained from 119 patients with acute PQ intoxication on 7 days after PQ ingestion. The areas with ground glass opacities (GGOs) were evaluated at five levels with the area measurement tool of the picture archiving and communication systems. Among 119 patients, 102 survived and 17 died. The plasma PQ levels were significantly higher in the non-survivors than in the survivors (2.6±4.0 µg/mL vs. 0.2±0.4 µg/mL, P=0.02). The area with GGOs was 2.0±6.4% in the survivors and 73.0± 29.9% in the non-survivors (P<0.001). No patients survived when the area with GGOs was more than 40% but all of the patients survived when the area affected by GGOs was less than 20%. In conclusion, the area of GGOs is a useful predictor of survival in acute PQ intoxication, especially in patients with low plasma PQ levels.

Keywords: Paraquat, Lung, High Resolution Computerized Tomography, Predictive Measure, Ground Glass Opacities

INTRODUCTION

Paraquat (1,1'-dimethyl-4, 4'-bipyridium dichloride, PQ) is one of the most widely used herbicides in the world. In humans, intentional or accidental ingestion of PQ is frequently fatal, resulting from significant lung injury (1). Over the past 30 yr, several methods for modifying the toxicity of PQ have been investigated including prevention of absorption from the gastrointestinal tract (2, 3), removal from the bloodstream (4, 5), prevention of accumulation in the lungs (6, 7), scavenging oxygen free radicals (8, 9), and prevention of lung fibrosis (10, 11). Unfortunately, most of these methods have not been effective; and the clinical outcome is determined by the degree of exposure to PQ. PQ mainly accumulates in the lung where it is retained even when the blood levels start to decrease. Subsequent redox cycling and the generation of reactive oxygen species (ROS) trigger the lung injury (12, 13). This is the reason why intentional or accidental PQ ingestion frequently causes death by respiratory failure (12).

There are many methods available for evaluation of the severity of lung injury in acute PQ intoxication, such as arterial blood gas analysis (aBGA), high-resolution computed tomography (HRCT) of the lung (14). Also there are some markers for alveolar destruction in acute PQ intoxication, such as ethane in exhaled breath (15), and plasma surfactant levels (16).

We previously reported that HRCT of the lung obtained 7 days after PQ ingestion was the best way to evaluate the fully developed acute PQ lung injury (14). The initial pathology of the lung is alveolitis, which develops into ground glass opacities (GGOs) in HRCT. The mortality rate is strongly associated with the plasma PQ levels as well as the amount of PQ ingested (17-19).

Considering the significant association of the PQ level with clinical outcome and the fact that respiratory failure is the main cause of death, the extent of the lung injury might be related to the plasma PQ levels. Nevertheless, the correlation of the extent of the lung injury with plasma PQ levels and clinical outcome is unknown. To determine the association of the development of GGOs with plasma PQ levels and clinical outcome, we analyzed the results of lung HRCT scans obtained in patients with acute PQ intoxication and attempted to determine the factors that distinguished the survivors from those that did not survive.

MATERIALS AND METHODS

This study was approved by ethics committee of Soonchunhyang University Cheonan Hospital and received a written consent from the patients and/or their family. From January to November 2007, 250 patients (143 males and 107 females) with acute PQ intoxication were admitted to the Institute of Pesticide Poisoning (IPP), Soonchunhyang University Cheonan Hospital. Standardized medical emergency procedures were conducted, which were summarized Table 1. Of 250 patients 119 (68 males and 51 females) were enrolled in this study. The inclusion criteria were patients who swallowed PQ and had acute PQ intoxication confirmed at the IPP with the dithionite urine test and/or plasma PQ levels. All of the enrolled patients had HRCT, 7 days after the PQ ingestion. The patients that died prior to 7 days were excluded from the study. HRCT was not done in 131 patients who were dead or hopelessly discharged within 7 days after PQ ingestion. As we described in a previous report (20), the survivor was defined as the patient who remained alive longer than 4 weeks after discharge.

Table 1.

Summary of treatment guidelines for acute paraquat (PQ) intoxication

graphic file with name jkms-24-636-i001.jpg

The mean age of the subjects was 43.3±12.2 yr. The ingestion amount (mean; 25.0±23.9 mL of 23% PQ; in Korea, most PQ products are a 23.0% solution) was determined by the reported mouthfuls ingested (one mouthful; 20 mL). The plasma PQ level of the subjects in the emergency room was 0.57±1.72 µg/mL retrospectively.

The time interval between PQ ingestion and arrival to the IPP was 21.2±30.3 hr.

Measurement of GGOs area on HRCT (Fig. 1)

Fig. 1.

Fig. 1

The areas of GGO were measured at five locations (the top of aortic arch, AP window, LUL bronchus, right inferior pulmonary vein and the top of left diaphragm respectively) using the measurements of the free-pen tool of PACS. To calculate the percents of lung injury, the sum of the areas of GGO (A) at the five levels were divided by the sum of the area of the total lungs (B) at the respective levels.

All HRCT scans were obtained 7 days after PQ poisoning using an eight-detector (LightSpeed Ultra, GE Healthcare) or 64-detector (LightSpeed VCT, GE Healthcare, U.S.A.) row scanners. The scanning parameters were 120 kVp, 200 or 300 mA, beam width 10 or 20 mm, and a pitch of 1.675 or 1.375. The 1.25 mm thin-section computed tomography (CT) scans with 5 mm intervals were acquired using retrospective reconstruction of raw data with a lung algorithm. HRCT images were available at a picture archiving and communication systems (PACS) with appropriate lung (window width, 1500, window level, -650) window settings on the monitors (four monitors, 2,048×2,560 matrix, 8-bit viewable gray, 500 cd/m2).

Two radiologists (specialzed in chest radiology) assessed the CT scans retrospectively. Decisions on the CT findings were reached by consensus. GGO is defined as hazy increased opacity with preservation of bronchial and vascular margins. The areas of GGOs were measured at five levels (at the levels of the top of aortic arch, aortopulmonary (AP) window, left upper lobe (LUL) bronchus, right inferior pulmonary vein, and the top of left diaphragm ) using the area measurement tool of the PACS. To calculate the extent of the lung injury, the sum of the area of GGOs at the five levels were divided by the sum of the areas of the total lung at the respective levels. Sometimes, it is difficult to differentiate GGOs from consolidation. In this study, if the area of focal consolidation is located within the boundary of GGO, it was regarded as area of GGOs. If the area of consolidation was located outside the area of GGO, this area was not included in the area of GGO.

Statistics

Data are presented as mean±SD and range of distribution when the distribution of data was unusually wide. Comparison of the parameters was performed with the t-test; but the Mann-Whitney test was applied for the time lag after PQ ingestion, estimated ingestion amount (mL), area with GGOs on HRCT (%), aspartate minotransferase (AST), alanine aminotransferase (ALT), amylase, and lipase because of the unusually wide distribution of the raw data.

RESULTS

Of 119 subjects, 102 survived and 17 died of acute PQ intoxication. There was no difference between the survivors and those who did not survive by age (42.4±12.3 yr vs. 44.6± 11.0 yr, P=0.488) or gender (male/female: 58/44 vs. 10/7, P=0.880). The WBC count was higher in those that did not survive than those survived (17,336.5±5,283.6 µL vs. 10,942.6 ±4,452.2 µL, P<0.001, Table 2). The estimated ingestion amount of PQ was lower in the survivors than in the dead (19.4±11.3 mL vs. 59.2±44.7 mL, P<0.001). Between the survivors and those that did not survive there was no significant difference in the interval between PQ ingestion and arrival to the emergency room, (22.1±31.9 hr vs. 16.2± 18.2 hr, P=0.45). However, the plasma PQ levels were significantly higher in those that did not survive than the survivors (2.6±4.0 µg/mL vs. 0.2±0.4 µg/mL, P=0.02).

Table 2.

Comparison of parameters between survivors and non-survivors

graphic file with name jkms-24-636-i002.jpg

All parameters are measured at emergency room at first hospital day except "area of GGO". Time lag after PQ ingestion, ingestion amount (mL), area of GGO, AST, ALT, amylase and lipase were compared with the Mann-Whitney Test (Range of data).

PQ, paraquat; HRCT, high resolution computerized tomography; AST, aspartate minotransferase; ALT, alanine aminotransferase.

The area of the lung with GGOs was 2.03±6.44% in the survivors and 73.0±29.93 in those that did not survive (P<0.001). The area of GGOs was zero in 40 out of 102 survivors and it was larger than 80% in 9 out of 17 patients that did not survive. Eight subjects (3 survivors and 5 non-survivors) had between 20-40% GGOs. No patients survived when the amount of GGOs was larger than 40%. In contrast, all patients with GGOs smaller than 20% survived (Fig. 2).

Fig. 2.

Fig. 2

Plasma PQ levels related to area of GGOs (%) and time interval after PQ ingestion. Note that no patient died when the area of lung GGOs was less than 20% of the total lung volume (A). While deaths occurred at low levels of PQ, almost near the bottom line (B).

DISCUSSION

Plasma PQ levels are known to be an excellent prognostic indicator for patient outcome (17-19). However, at the bedside, it is difficult to predict survivors even when the PQ levels are known. Recently, we published an analysis of our clinical observations, which showed an association between plasma PQ levels and clinical outcome in 375 patients with acute PQ intoxication (20). Based on the information from the plasma PQ levels it was hard to predict who would survive because many patients died even at low PQ levels. Therefore, better predictive measures are needed for patients presenting with acute PQ intoxication. Because lung injury is the main cause of death after acute PQ intoxication, the lung abnormalities would be a better predictive factor.

The initial pathology of PQ intoxication is an alveolitis, which is later shown as GGOs in HRCT. In diagnosing the lung injury caused by PQ, HRCT is employed as a sensitive and specific tool. We evaluated the severity of the lung injury by measuring the extent of involved lung. The results of this study showed that there were no deaths when the area of GGOs was smaller than 20% of the total lung volume. In addition, there were no survivors when the area of GGOs was larger than 40% of the total lung volume. When 20% and 40% of the total lung volume was affected, some patients died and others survived.

For those patients who died within 7 days before they took the HRCT, we presume that GGO might have developed across their entire lungs. The GGO-inflicted patches were distributed unevenly across the area. There was no such GGO area in the 40 cases out of 119 survivors, more than 80% of such inflicted area in the 9 cases out of the 17 non-survivors. Eight cases were transitional between 20-40% of GGO trace in the lung. In these transitional cases, 3 cases survived and 5 did not.

In conclusion, given the fact that the minimum fatal PQ level can be very low in practice (Fig. 2), the area of GGO in the lung is an additional useful predictor for the survival, especially when the PQ level is low.

References

  • 1.Goldfrank LR, Flomenbaum NE, Neal NA, Howland MA, Hoffman RS, Nelson LS. Goldfrank's Toxicologic emergencies. 7th ed. Chicago: McGraw-Hill; 2002. pp. 1397–1400. [Google Scholar]
  • 2.Hong SY, Hwang KY, Lee EY, Eun SW, Cho SR, Han CS, Park YH, Chang SK. Effect of vitamin C on plasma total antioxidant status in patients with paraquat intoxication. Toxicol Lett. 2002;126:51–59. doi: 10.1016/s0378-4274(01)00431-3. [DOI] [PubMed] [Google Scholar]
  • 3.Onyon LJ, Volans GN. The epidemiology and prevention of paraquat poisoning. Hum Toxicol. 1987;6:19–29. doi: 10.1177/096032718700600104. [DOI] [PubMed] [Google Scholar]
  • 4.Meredith TJ, Vale JA. Treatment of paraquat poisoning in man: methods to prevent absorption. Hum Toxicol. 1987;6:49–55. doi: 10.1177/096032718700600108. [DOI] [PubMed] [Google Scholar]
  • 5.Okonek S, Hofmann A, Henningsen B. Efficacy of gut lavage, hemodialysis, and hemoperfusion in the therapy of paraquat or diquat intoxication. Arch Toxicol. 1976;36:43–51. doi: 10.1007/BF00277562. [DOI] [PubMed] [Google Scholar]
  • 6.Okonek S. Hemoperfusion in toxicology. Basic considerations of its effectiveness. Clin Toxicol. 1981;18:1185–1198. doi: 10.3109/00099308109035058. [DOI] [PubMed] [Google Scholar]
  • 7.Suntres ZE. Role of antioxidants in paraquat toxicity. Toxicology. 2002;180:65–77. doi: 10.1016/s0300-483x(02)00382-7. [DOI] [PubMed] [Google Scholar]
  • 8.Lock EA, Smith LL, Rose MS. Inhibition of paraquat accumulation in rat lung slices by a component of rat plasma and a variety of drugs and endogenous amines. Biochem Pharmacol. 1976;25:1769–1772. doi: 10.1016/0006-2952(76)90413-5. [DOI] [PubMed] [Google Scholar]
  • 9.Ross JH, Krieger RI. Structure activity correlations of amines inhibiting activity uptake of paraquat (methyl viologen) into rat lung slices. Toxicol Appl Pharmacol. 1981;59:238–249. doi: 10.1016/0041-008x(81)90194-0. [DOI] [PubMed] [Google Scholar]
  • 10.Kitazawa Y, Matsubara M, Takeyama N, Tanaka T. The role of xanthine oxidase in paraquat intoxication. Arch Biochem Biophys. 1991;288:220–224. doi: 10.1016/0003-9861(91)90187-n. [DOI] [PubMed] [Google Scholar]
  • 11.Petry TW, Wolfgang GH, Jolly RA, Ochoa R, Donarski WJ. Antioxidant-dependent inhibition of diquat-induced toxicity in vivo. Toxicology. 1992;74:33–43. doi: 10.1016/0300-483x(92)90041-c. [DOI] [PubMed] [Google Scholar]
  • 12.Lin JL, Leu ML, Liu YC, Chen GH. A prospective clinical trial of pulse therapy with glucocorticoid and cyclophosphamide in moderate to severe paraquat-poisoned patients. Am J Respir Crit Care Med. 1999;159:357–360. doi: 10.1164/ajrccm.159.2.9803089. [DOI] [PubMed] [Google Scholar]
  • 13.Webb DB, Williams MV, Davies BH, James KW. Resolution after radiotherapy of severe pulmonary damage due to paraquat poisoning. Br Med J (Clin Res Ed) 1984;288:1259–1260. doi: 10.1136/bmj.288.6426.1259. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Lee SH, Lee KS, Ahn JM, Kim SH, Hong SY. Paraquat poisoning of the lung: thin-section CT findings. Radiology. 1995;195:271–274. doi: 10.1148/radiology.195.1.7892484. [DOI] [PubMed] [Google Scholar]
  • 15.Hong SY, Gil HW, Yang JO, Lee EY, Na JO, Seo KH, Kim YH. Clinical implications of the ethane in exhaled breath in patients with acute paraquat intoxication. Chest. 2005;128:1506–1510. doi: 10.1378/chest.128.3.1506. [DOI] [PubMed] [Google Scholar]
  • 16.Gil HW, Hong JR, Park JH, Yang JO, Lee EY, Hong SY. Plasma surfactant D in patients following acute paraquat intoxication. Clin Toxicol (Phila) 2007;45:463–467. doi: 10.1080/15563650701338138. [DOI] [PubMed] [Google Scholar]
  • 17.Proudfoot AT, Stewart MS, Levitt T, Widdop B. Paraquat poisoning: significance of plasma-paraquat concentrations. Lancet. 1979;2:330–332. doi: 10.1016/s0140-6736(79)90345-3. [DOI] [PubMed] [Google Scholar]
  • 18.Lee EY, Hwang KY, Yang JO, Hong SY. Predictors of survival after acute paraquat poisoning. Toxicol Ind Health. 2002;18:201–206. doi: 10.1191/0748233702th141oa. [DOI] [PubMed] [Google Scholar]
  • 19.Hong SY, Yang DH, Hwang KY. Associations between laboratory parameters and outcome of paraquat poisoning. Toxicol Lett. 2000;118:53–59. doi: 10.1016/s0378-4274(00)00264-2. [DOI] [PubMed] [Google Scholar]
  • 20.Gil HW, Kang MS, Yang JO, Lee EY, Hong SY. Association between plasma paraquat level and outcome of paraquat poisoning in 375 paraquat poisoning patients. Clin Toxicol (Phila) 2008;46:515–518. doi: 10.1080/15563650701549403. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Korean Medical Science are provided here courtesy of Korean Academy of Medical Sciences

RESOURCES